Join to View Full Profile
WashU Medicine Mailcode 8005-94-01660 S. Euclid AveSt. Louis, MO 63110
Phone+1 314-362-5060
Dr. Gage is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Brian F Gage, MD, MSc is a Professor of Medicine at WashU in St. Louis and an attending physician at Barnes-Jewish Hospital. He received his MD from University of California San Diego (UCSD) School of Medicine and his MSc in health services research from Stanford University. He has been in practice more than 20 years. He developed the CHADS2 stroke prediction rule for atrial fibrillation and the non-profit website www.WarfarinDosing.org. His publications have been cited more than 10,000 times.
Education & Training
Stanford UniversityMSc, Health Service Research, 1992 - 1994
University of Arizona College of Medicine-PhoenixResidency, Internal Medicine, 1991 - 1992
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1989 - 1991- University of Arizona College of Medicine-PhoenixInternship, Internal Medicine, 1988 - 1989
University of California San Diego School of MedicineClass of 1988
Certifications & Licensure
CA State Medical License 1992 - Present
MO State Medical License 1995 - 2027
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- AOA Washington University in St. Louis, 2015
Clinical Trials
- Genetics Informatics Trial (GIFT) of Warfarin to Prevent DVT Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- Risk factors for anticoagulant-related bleeding in cancer: traditional and cancer-specific factors.Alexa Loncharich, Brian F Gage, Suhong Luo, Martin Schoen, Amber Afzal
Blood Vessels, Thrombosis & Hemostasis. 2026-02-01 - Association of anticoagulant therapy with bleeding in patients with chronic liver disease: A case-cross over study using the National Veterans Health Administration da...Amir Mahmoud, Kristen M Sanfilippo, Brian F Gage, Suhong Luo, Amber Afzal
Thrombosis Research. 2025-12-01 - A Combined Intravenous and Oral Metoprolol Regimen to Reduce Perioperative Myocardial Injury: The ORION Trial.Peter Nagele, Mohammad A Helwani, Eslam Samaha, Andreas Koköfer, Frank Brown
Anesthesia and Analgesia. 2025-10-17
Press Mentions
Missouri Construction Workers Face Frequent Injuries, Often Prescribed OpioidsJanuary 8th, 2021
Low-Intensity Warfarin Not Noninferior in Hip, Knee SurgeryNovember 5th, 2019
Anticoagulant Type May Influence Fracture Risk in A-fib PatientsOctober 21st, 2019
Grant Support
- Pharmacogenetic Refinement of the Warfarin Dose Using Machine LearningWASHINGTON UNIVERSITY2024–2028
- Genetics-Informatics Trial (GIFT) Of Warfarin To Prevent DVTNational Heart, Lung, And Blood Institute2009–2011
- Vitamin K, VKORC1 Polymorphisms, And Osteoporotic FracturesNational Center For Research Resources2007
- Pharmacogenetics, Biomarkers, And Antithrombotic TherapyNational Center For Research Resources2006–2007
- Pharmacogenetics, Biomarkers, And Antithrombotic TherapyNational Heart, Lung, And Blood Institute2003–2006
External Links
- Warfarin Dosinghttp://WarfarinDosing.org
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
